Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00258401 · ClinicalTrials.gov registry record · NA

Low-Residue Diet in Treating Diarrhea in Patients Receiving Pelvic Radiation Therapy.

A NA study, sponsored by Case Comprehensive Cancer Center.

Completed
Registry status
NA
Development phase
11
Enrollment target

NCT00258401 is a NA study that has completed, run by Case Comprehensive Cancer Center. The registered enrollment target is 11 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00258401, a NA study, has completed, sponsored by Case Comprehensive Cancer Center.

COMPLETED
Registry status
NA
Development phase
11 participants
Enrollment target

Study Summary

RATIONALE: Eating a diet low in residue (fiber, fat, and certain milk or vegetable products) may help prevent or reduce diarrhea caused by pelvic radiation therapy. PURPOSE: This randomized clinical trial is studying a low-residue diet to see how well it works compared to no dietary intervention in treating diarrhea in patients who are undergoing radiation therapy to the pelvis for uterine, cervical, or prostate cancer.

Interventions

  • PROCEDURE quality-of-life assessment
  • DIETARY_SUPPLEMENT dietary intervention
  • PROCEDURE management of therapy complications

Trial Details

FieldValue
Enrollment Target 11 participants
Start Date 2005-05
Est. Completion 2006-06
Phase NA

Sponsor

Case Comprehensive Cancer Center

407 total trials

What the Registry Record Tells You About NCT00258401

The ClinicalTrials.gov registry entry for NCT00258401 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Case Comprehensive Cancer Center, which has 407 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which quality-of-life assessment is the first listed.

NCT00258401 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00258401 about?

NCT00258401 is a clinical study titled "Low-Residue Diet in Treating Diarrhea in Patients Receiving Pelvic Radiation Therapy.". RATIONALE: Eating a diet low in residue (fiber, fat, and certain milk or vegetable products) may help prevent or reduce diarrhea caused by pelvic radiation therapy. PURPOSE: This randomized clinical trial is studying a low-residue diet to see how well it works compared to no dietary intervention in...

What is the current status of trial NCT00258401?

This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2005-05. Estimated completion is 2006-06.

What interventions are being tested in trial NCT00258401?

The interventions under investigation include: quality-of-life assessment (PROCEDURE), dietary intervention (DIETARY_SUPPLEMENT), management of therapy complications (PROCEDURE).

Who is sponsoring clinical trial NCT00258401?

This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.